Vitrolife AB Statistics
Total Valuation
Vitrolife AB has a market cap or net worth of 1.90 billion. The enterprise value is 2.01 billion.
| Market Cap | 1.90B |
| Enterprise Value | 2.01B |
Important Dates
The next estimated earnings date is Thursday, October 23, 2025.
| Earnings Date | Oct 23, 2025 |
| Ex-Dividend Date | May 2, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 75.04M |
Valuation Ratios
The trailing PE ratio is 39.72 and the forward PE ratio is 30.88.
| PE Ratio | 39.72 |
| Forward PE | 30.88 |
| PS Ratio | 5.10 |
| PB Ratio | 1.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 33.53 |
| P/OCF Ratio | 26.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.15, with an EV/FCF ratio of 35.51.
| EV / Earnings | 42.07 |
| EV / Sales | 5.44 |
| EV / EBITDA | 17.15 |
| EV / EBIT | 27.69 |
| EV / FCF | 35.51 |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.41 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | 3.70 |
| Interest Coverage | 7.09 |
Financial Efficiency
Return on equity (ROE) is 3.45% and return on invested capital (ROIC) is 2.85%.
| Return on Equity (ROE) | 3.45% |
| Return on Assets (ROA) | 2.58% |
| Return on Invested Capital (ROIC) | 2.85% |
| Return on Capital Employed (ROCE) | 4.29% |
| Revenue Per Employee | 324,647 |
| Profits Per Employee | 41,715 |
| Employee Count | 1,169 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 3.63 |
Taxes
In the past 12 months, Vitrolife AB has paid 16.40 million in taxes.
| Income Tax | 16.40M |
| Effective Tax Rate | 25.53% |
Stock Price Statistics
The stock price has decreased by -7.82% in the last 52 weeks. The beta is 1.78, so Vitrolife AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -7.82% |
| 50-Day Moving Average | 14.94 |
| 200-Day Moving Average | 17.53 |
| Relative Strength Index (RSI) | 28.71 |
| Average Volume (20 Days) | 2 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitrolife AB had revenue of 372.37 million and earned 47.85 million in profits. Earnings per share was 0.35.
| Revenue | 372.37M |
| Gross Profit | 219.15M |
| Operating Income | 73.09M |
| Pretax Income | 64.25M |
| Net Income | 47.85M |
| EBITDA | 112.84M |
| EBIT | 73.09M |
| Earnings Per Share (EPS) | 0.35 |
Balance Sheet
The company has 96.85 million in cash and 209.58 million in debt, giving a net cash position of -112.73 million.
| Cash & Cash Equivalents | 96.85M |
| Total Debt | 209.58M |
| Net Cash | -112.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 10.31 |
| Working Capital | 162.16M |
Cash Flow
In the last 12 months, operating cash flow was 72.88 million and capital expenditures -16.19 million, giving a free cash flow of 56.68 million.
| Operating Cash Flow | 72.88M |
| Capital Expenditures | -16.19M |
| Free Cash Flow | 56.68M |
| FCF Per Share | n/a |
Margins
Gross margin is 58.85%, with operating and profit margins of 19.63% and 12.85%.
| Gross Margin | 58.85% |
| Operating Margin | 19.63% |
| Pretax Margin | 17.26% |
| Profit Margin | 12.85% |
| EBITDA Margin | 30.30% |
| EBIT Margin | 19.63% |
| FCF Margin | 15.22% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | 25.81% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 32.75% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 0.36% |
| Earnings Yield | 2.52% |
| FCF Yield | 2.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 1, 2018. It was a forward split with a ratio of 1.25.
| Last Split Date | Jun 1, 2018 |
| Split Type | Forward |
| Split Ratio | 1.25 |
Scores
Vitrolife AB has an Altman Z-Score of 4.9 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.9 |
| Piotroski F-Score | 8 |